ZEUS

Giel Capital Corporation

Application Filed: 2018-08-04
Trademark Application Details
Trademark Logo ZEUS

Mark For: ZEUS™ trademark registration is intended to cover the category of pharmaceuticals for the treatment of erectile dysfunction. [all]

Status

2021-07-05 UTC
DEAD APPLICATION Refused Dismissed or Invalidated
This trademark application was refused, dismissed, or invalidated by the Office and this application is no longer active.


Research OneLook Acronym Finder
Serial Number88065647
Mark Literal ElementsZEUS
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeTRADEMARK
RegisterPRINCIPAL
Current LocationTMO LAW OFFICE 122 - EXAMINING ATTORNEY ASSIGNED 2019-07-05
Basis1(b)
Class StatusACTIVE
Primary US Classes
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseNo
Current UseNo
Intent To UseYes
Filed ITUYes
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Law Office AssignedN40
Employee NameSALES, HEATHER ALISON

Timeline

2018-08-04Application Filed
2019-05-29Abandon
2019-07-05Location: TMO LAW OFFICE 122 - EXAMINING ATTORNEY ASSIGNED
2019-07-05Status: Abandoned because the applicant failed to respond or filed a late response to an Office action. To view all documents in this fi
2019-07-05Status: Dead/Abandoned
2019-07-05Transaction Date

Trademark Parties (Applicants & Owners)

Party: GIEL CAPITAL CORPORATION
AddressSUITE 206 4000 ISLAND BLVD. AVENTURA, FLORIDA UNITED STATES 33160
Legal Entity TypeCorporation
Legal Entity StateFLORIDA

Documents

DrawingJPEG2018-08-04
TEAS Plus New ApplicationMULTI2018-08-04
Notation to FileXML2018-11-23
XSearch Search SummaryXML2018-11-23
Offc Action OutgoingMULTI2018-11-26
Notice of AbandonmentXML2019-07-05

Attorney of Record

GIEL CAPITAL CORPORATION
GIEL CAPITAL CORPORATION
4000 ISLAND BLVD.
SUITE 206
AVENTURA, FL 33160

Good, Services, and Codes

(ABANDONED)
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceuticals for the treatment of erectile dysfunction

International Codes:5
U.S. Codes:006,018,044,046,051,052
Type CodeType
GS0051Pharmaceuticals for the treatment of erectile dysfunction

Trademark Filing History

DescriptionDateProceeding Number
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND2019-07-05
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE2019-07-05
NOTIFICATION OF NON-FINAL ACTION E-MAILED2018-11-266325
NON-FINAL ACTION WRITTEN2018-11-2693060
NON-FINAL ACTION E-MAILED2018-11-266325
ASSIGNED TO EXAMINER2018-11-2393060
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2018-08-10
NEW APPLICATION ENTERED IN TRAM2018-08-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed